HOME >> BIOLOGY >> NEWS
Newly created cancer stem cells could aid breast cancer research

CAMBRIDGE, Mass. (August 13, 2007) In some ways, certain tumors resemble bee colonies, says pathologist Tan Ince. Each cancer cell in the tumor plays a specific role, and just a fraction of the cells serve as queens, possessing the unique ability to maintain themselves in an unspecialized state and seed new tumors. These cells can also divide and produce the worker cells that form the bulk of the tumor.

These queens are cancer stem cells. Now the lab of Whitehead Member Robert Weinberg has created such cells in a Petri dish by isolating and transforming a particular population of cells from human breast tissue. After being injected with just 100 of these transformed cells, mice developed tumors that metastasized (spread to distant tissues).

The operational definition of a cancer stem cell is the ability to initiate a tumor, so these are cancer stem cells, declares Weinberg, who is also an MIT professor of biology.

Ince didnt set out to engineer these potent cells. As a post-doctoral researcher in the Weinberg lab and gynecologic pathologist at Brigham and Womens Hospital, he was simply trying to create breast cancer models that look like real human tumors under the microscope and behave like those seen in many patients.

In more than 90 percent of human breast tumors, cancer cells resemble those lining our bodys cavities. A trained pathologist can spot the similarities under a microscope. But the cancer cells previously engineered from normal breast cells for laboratory studies looked different. Ince suspected that researchers were transforming the wrong type of cells.

Now an independent investigator at Brigham and Womens Hospital and an instructor at Harvard Medical School, Ince developed a recipe for a new chemically defined culture medium and managed to grow a different type of human breast cell that ordinarily dies in culture. He transformed it into a cancer cell by inserting specific genes through a standard
'"/>

Contact: Alyssa Kneller
kneller@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
13-Aug-2007


Page: 1 2 3

Related biology news :

1. Newly identified mechanism for silencing genes points to possible anti-cancer strategies
2. Newly discovered platform for processing dietary fat
3. Newly discovered West Coast arrhythmias cause
4. Newly discovered fish named after New York aquarium biologist
5. Newly discovered immune defense may be impaired in CF airways
6. Newly identified strains of Chlamydia trachomatis could produce new diseases
7. Newly discovered proteins associated with cystic fibrosis
8. Newly discovered gene may hold clues to evolution of human brain capacity
9. Newly identified protein complex sheds light on axon growth mechanism
10. Newly discovered protein could hold key to preventing heart disease
11. Newly discovered protein kills anthrax bacteria by exploding their cell walls

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2020)... ... January 21, 2020 , ... ... validation strategies, supporting global regulatory applications, and executing global clinical trial operations. ... Journal as a fastest growing company, and ISO 9001:2015 certification with the ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... offering complimentary overnight shipping to its nationwide practice network partners. Not only ... due to volume in its Network the biologics themselves are less expensive. , ...
(Date:1/7/2020)... ... 2020 , ... Myant Inc. , the pioneers in Textile Computing™, will ... life its vision of a world where textile-based interfaces knitted into everyday objects form ... and the physical IoT-enabled environment. The experience at Myant’s booth will challenge visitors to ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... ... January 24, 2020 , ... ... RedySmart™ mass flow meters and controllers ideal for BioPharm OEMS. Sierra ... to antiquated rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies and Cardea Bio ... partners have agreed to co-develop and market a portfolio of CRISPR QC products ... Over the longer-term, the parties aim to develop a COBO branded QC device ...
(Date:1/10/2020)... ... January 09, 2020 , ... GenScript Biotech Corp., ... Biotech Global Forum on Jan. 14 in San Francisco, coinciding with the JP ... and the Booming China Market," will feature gene and cell therapy leaders in ...
(Date:1/7/2020)... ... ... Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated to developing cancer metastasis ... DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, to its Board of Directors. ... Chand and Lee as new directors. They will be of great help in advancing ...
Breaking Biology Technology:
Cached News: